Skip to main content
. Author manuscript; available in PMC: 2020 Apr 23.
Published in final edited form as: Pharm Res. 2016 Dec 27;34(3):619–628. doi: 10.1007/s11095-016-2090-2

Fig 3.

Fig 3.

Individual atazanavir (ATV) area under the concentration time curve (AUC) and maximum concentration (Cmax) values for administration of ATV/RTV alone (Treatment A), pretreatment with rabeprazole (Treatment B) and the addition of betaine HCl (Treatment C).